2028年までのアジア太平洋免疫組織化学市場予測 - アプリケーション（診断および薬物検査）、製品（抗体、機器、試薬、キット）、およびエンドユーザー（病院および診断研究所、研究機関、その他）ごとの新型コロナウイルス感染症の影響と地域分析）

市場紹介

APAC は、免疫組織化学の地域市場で最も急速に成長しています。中国、インド、日本、韓国、オーストラリア、およびその他のアジア太平洋地域がこの地域の市場に大きく貢献しています。 2021年に中国が市場をリードした。市場の成長は、研究開発活動の増加、発展途上国のヘルスケア分野への投資の増加、規制当局のアウトソーシングと医薬品開発者の協力の増加によるものである。市場関係者は製品を発売しています。たとえば、2020年8月にギリアド・サイエンシズ社は、中国で成人および青少年の医療に使用されるHIV予防薬ツルバダの承認を取得した。この承認は健康な人々のHIV予防に役立ちます。アジアおよび太平洋地域では、数多くの感染症が出現、再興、または再発の流行を引き起こしています。人々がより頻繁に旅行し、より人口密度の高い地域に住み、野生動物とより密接に接触するようになったことで、新興感染症が急速に蔓延する可能性が高まっています。現在の新型コロナウイルス感染症の状況により、病気の診断を向上させるために、国民の間でのインフルエンザウイルスの監視も強化されています。中国国家衛生健康委員会（NHC）によると、2020年3月26日までに中国で報告されたコロナウイルス感染者数は合計81,285人、ウイルス発生による死者は合計3,287人となった。この病気は初期段階では急速に伝染しました。ただし、ロタウイルスウイルス、AE型肝炎ウイルス、デング熱ウイルスなどのさまざまなウイルス感染症による病気の蔓延も、予測期間中に市場を牽引すると予想されます。このこと、再興感染症の増加、診断能力の向上、ウイルス疾患の理解を深めるための政府プログラムの強化により、今後数年間で免疫組織化学市場の成長が促進されると予想されます。

APAC 諸国、特にインド、新型コロナウイルス感染症の流行により大きな影響を受けています。サプライチェーンの混乱と、新型コロナウイルス感染症の治療における効率的な治療法に対する膨大な需要により、アジア太平洋地域の医療研究業界は重大な状況に陥っています。新型コロナウイルスの感染拡大を抑制するために禁止措置が講じられている。新型コロナウイルス感染症のパンデミックは、地域の経済に悪影響を及ぼしています。社会経済は深刻な影響を受け、マイナスのインフレ、GDP、地域の失業率の上昇が見られました。中国、日本、シンガポール、韓国などの国々では、臨床試験への関心が高まっています。欧米諸国のコスト高も、APACへの医療事務のアウトソーシングの流れの一因となっている。アジア市場への売上を拡大するために、製薬会社は医薬品、機器、体外診断薬に対する新たな規制環境の変化を認識し始めています。アジアでは、GMP基準、薬価管理、医療機器規制制度の変更など、新規または改良された規制が頻繁に導入されています。現在の基準の取得または改善の一環として、第三者の指導とアドバイスが必要です。サードパーティのアウトソーシングサービスプロバイダーが、APAC の関連市場をサポートする上で重要な役割を果たしていることが増えています。しかし、制御手順、人々の意識、ワクチン接種の利用可能性、関連市場における企業に対する政府の支援政策により、パンデミックの初期段階に比べて市場は安定しています。

< u>市場の概要とダイナミクス

APACの免疫組織化学市場は、2021年の4億8,376万米ドルから2028年までに8億1,800万米ドルに成長すると予想されています。 2021 年から 2028 年にかけて 7.8% の CAGR で成長すると推定されています。免疫組織化学 (IHC) は、特定の疾患の抗原の組織決定と分布のための重要なアプリケーションであるモノクローナルおよびポリクローナル抗体を指します。主に、デング熱、肝炎、ヒト免疫不全ウイルス (HIV) などのいくつかの感染症を検出するために使用されます。肥満、がん、糖尿病、心臓病、脳卒中などの慢性病状も、これらの病気の診断に役立つ免疫組織化学の主な応用分野であると考えられています。糖尿病は、この地域全体の高齢者人口において高い割合で蔓延しています。糖尿病の有病率は、過体重や肥満の人に多く見られます。肥満率は、この地域全体の先進国だけでなく発展途上国でも急速に増加しています。不健康なライフスタイルや座りっぱなしの生活などは、肥満者数増加の主な要因の一つです。心血管疾患 (CVD) には、脳血管疾患、リウマチ性心疾患、冠状動脈性心疾患、およびその他の状態が含まれます。これは、この地域全体の罹患率と死亡率の最も重要な原因です。さらに、この地域全体でがんの罹患率と死亡率が上昇しており、がんが主な死因となっている。このような慢性疾患や感染症の発生率の増加により、APAC 地域全体でイムノアッセイ検査の需要が生じることが予想されます。

主要市場セグメント

製品の面では、抗体セグメントが2020年のAPAC免疫組織化学市場で最大のシェアを占めました。アプリケーションの面では、診断セグメントが2020年のAPAC免疫組織化学市場でより大きな市場シェアを占めました。さらに、 2020 年のエンドユーザーベースでは、病院および診断研究所セグメントが APAC 免疫組織化学市場でより大きなシェアを占めました。

リストされている主要な供給源と企業

APAC 免疫組織化学市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。レポートに記載されている主要企業は、Abcam plc です。アジレント・テクノロジー株式会社;バイオSB;バイオラッドラボラトリーズ株式会社;セル・シグナリング・テクノロジー株式会社;ダナハー。 F. ホフマン・ラ・ロッシュ株式会社;メルクKGaA;パーキンエルマー株式会社;および THERMO FISHER SCIENTIFIC INC。

購入理由レポート

APAC の免疫組織化学市場の状況を理解し、大きな利益を保証できる可能性が最も高い市場セグメントを特定する
絶えず変化する市場を理解することで競争に先んじるAPAC 免疫組織化学市場の競争環境を把握する
最も売上が見込める市場セグメントを特定することで、APAC 免疫組織化学市場における M&A やパートナーシップ取引を効率的に計画する
洞察力と知識に基づいたビジネス上の意思決定を支援します。 APAC 免疫組織化学市場のさまざまなセグメントの市場パフォーマンスの包括的な分析
APAC 地域の 2021 年から 2028 年までのさまざまなセグメント別の市場収益予測を取得します。

APAC 免疫組織化学市場セグメンテーション

>アジア太平洋免疫組織化学市場 - 製品別

装置
- スライド染色システム
- 組織マイクロアレイシステム
- 組織処理システム
- スライドスキャナ
- その他の機器
抗体
- 一次抗体
- 二次抗体
試薬
- 組織学的染色
- ブロッキング試薬および固定試薬
- >発色基質
- 固定試薬
- 安定剤
- 有機溶媒
- タンパク質分解酵素
- 希釈剤
キット

APAC 免疫組織化学市場 - 用途別

診断
- がん
- 感染症
- 自己免疫疾患
- 糖尿病
- 腎臓疾患
- その他
薬物検査

APAC 免疫組織化学市場 - エンドユーザー別

病院および診断検査機関
研究機関
その他

アジア太平洋免疫組織化学市場 - 国別

アジア太平洋の免疫組織化学市場 - 会社概要

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Immunohistochemistry Market – By Product

1.3.2 APAC Immunohistochemistry Market – By Application

1.3.3 APAC Immunohistochemistry Market – By End User

1.3.4 APAC Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalating Incidences of Chronic and Infectious Diseases

5.1.2 Surging R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Complications Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Burgeoning Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Growing Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – APAC Analysis

6.1 APAC Immunohistochemistry Market Revenue Forecast and Analysis

7. APAC Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. APAC Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. APAC Immunohistochemistry Market – Country Analysis

10.1 APAC Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 Overview

10.1.2 APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.3 India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.6 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.6.2.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.6.2.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.6.2.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.6.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.6.3.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.6.4 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 4. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 5. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 11. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 12. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 18. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 19. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 25. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 26. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 28. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 29. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 30. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 31. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 32. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 33. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 34. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 35. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 36. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 37. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 38. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 39. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 40. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 41. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 42. Organic Developments Done By Companies

Table 43. Inorganic developments done by Companies

Table 44. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Immunohistochemistry Market Segmentation

Figure 2. APAC Immunohistochemistry Market Segmentation, By Country

Figure 3. APAC Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market

Figure 8. APAC Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. APAC Immunohistochemistry Market Overview, by Country (2021)

Figure 43. APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample